Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method

scientific article

Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VACCINE.2009.02.035
P698PubMed publication ID19428864

P50authorDaniil KorenkovQ42115794
Larisa RudenkoQ42115804
Svetlana DoninaQ90213430
Galina PetukhovaQ105046068
P2093author name stringTatiana Chirkova
Anatoly Naikhin
P2860cites workRapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysQ25939005
Human lymphocyte apoptosis after exposure to influenza A virusQ33842341
Vaccination strategies for mucosal immune responsesQ33975703
A time to kill: viral manipulation of the cell death programQ34134292
Nasal vaccinesQ34343241
Influenza virus induction of apoptosis by intrinsic and extrinsic mechanismsQ35213616
Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infectionQ43654251
The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulationQ44204966
IgA, IgA subclasses, and secretory component levels in oral fluid collected from subjects after parental influenza vaccinationQ44356910
Apoptosis and reduced influenza A virus specific CD8+ T cells in aging miceQ45732396
Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infectionQ45735758
Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccinationQ45745329
Destruction of lymphocytes by a virulent avian influenza A virusQ45843448
IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administrationQ47773345
Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo.Q52010404
Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88Q57111471
The Waldeyer Ring Equivalent in the Rat: a Model for Analysis of Oronasopharyngeal Immune ResponsesQ58286674
Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenaseQ71565986
Isolation and characterization of mouse nasal-associated lymphoid tissueQ73233436
Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectivelyQ77530752
Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosaQ77838475
P433issue19
P407language of work or nameEnglishQ1860
P921main subjectantibodyQ79460
influenza vaccineQ383260
attenuated vaccineQ1810913
P304page(s)2580-2587
P577publication date2009-02-20
P1433published inVaccineQ7907941
P1476titleComparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method
P478volume27

Reverse relations

cites work (P2860)
Q39451665Alveolar macrophages contribute to respiratory tolerance by inducing FoxP3 expression in naive T cells
Q30382809Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.
Q30365079Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
Q30399923Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets
Q30394240Human monoclonal antibodies broadly neutralizing against influenza B virus
Q98189278Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets
Q30226518Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.
Q38028996Mucosal immunity and nasal influenza vaccination
Q35066281Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue
Q30205252Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus
Q30148631Tackling a novel lethal virus: a focus on H7N9 vaccine development.
Q35103033The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms